Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Pulmonary Hypertension

  Free Subscription


09.02.2026

1 Acad Radiol
2 Adv Ther
1 Biomed Pharmacother
1 BMJ Case Rep
1 Braz J Med Biol Res
1 Cardiol Rev
1 Clin Radiol
1 Clin Rheumatol
1 FASEB J
2 Front Cardiovasc Med
1 Hypertension
1 Int Immunopharmacol
1 Int J Rheum Dis
1 J Cardiothorac Surg
1 J Ethnopharmacol
1 J Mol Cell Cardiol
1 J Perinatol
1 J Thorac Cardiovasc Surg
1 JMIR Cardio
1 Med Lett Drugs Ther
1 Medicine (Baltimore)
1 Mol Cell Biochem
1 Pediatr Neonatol
1 PLoS One
1 Pol Arch Intern Med
1 Pulm Circ
1 Pulm Med
1 Respir Med
2 Respirology
2 Rheumatology (Oxford)
1 Saudi Med J
2 Sci Rep
1 Sci Transl Med
1 Stem Cell Res Ther
1 Zhonghua Jie He He Hu Xi Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acad Radiol

  1. PAEZ-CARPIO A, Domenech-Ximenos B, Serrano E, Cornellas L, et al
    Vascular Obstruction Scoring on Dual-energy CT, Cone-beam CT and Digital Subtraction Angiography: Correlation with Invasive Hemodynamics in Chronic Thromboembolic Pulmonary Hypertension.
    Acad Radiol. 2026 Feb 3:S1076-6332(26)00019-X. doi: 10.1016/j.acra.2026.
    PubMed         Abstract available


    Adv Ther

  2. MELENDRES-GROVES LD, Channick RN, Chin KM, McLaughlin VV, et al
    Characteristics, Treatment Patterns and Outcomes of Patients with Pulmonary Arterial Hypertension by Race and Ethnicity Using Real-World Data from the Combined OPUS/OrPHeUS Studies.
    Adv Ther. 2026;43:231-254.
    PubMed         Abstract available

  3. CLARKE M, Ataya A, Turkin AM, Parikh R, et al
    Transitioning Between Treprostinil Formulations: Evidence and Strategies.
    Adv Ther. 2026;43:20-48.
    PubMed         Abstract available


    Biomed Pharmacother

  4. WANG J, Wang Y, Shi R, Xu S, et al
    Allicin ameliorates right heart dysfunction in rats suffering from pulmonary arterial hypertension by regulating Ca(2+) communication between the sarcoplasmic reticulum and mitochondria.
    Biomed Pharmacother. 2026;195:119046.
    PubMed         Abstract available


    BMJ Case Rep

  5. SATPATHY SK, Paswal CM, Gupta N, Soni JP, et al
    Endomyocardial calcification with pulmonary and systemic hypertension in a term neonate with multisystem inflammatory syndrome of newborn (MIS-N).
    BMJ Case Rep. 2026;19:e270053.
    PubMed         Abstract available


    Braz J Med Biol Res

  6. ROQUE AC, Stockmann IS, Acencio MMP, Silva CSR, et al
    IL-6 and TGF-beta1 as biomarkers of schistosomiasis-associated pulmonary hypertension in a murine model.
    Braz J Med Biol Res. 2026;59:e15221.
    PubMed         Abstract available


    Cardiol Rev

  7. SEPLOWE M, Isath A, Michaud L, Frishman WH, et al
    Pulmonary Artery Hypertension: Fifty Years Following Pneumonectomy in Infancy.
    Cardiol Rev. 2026;34:175-177.
    PubMed         Abstract available


    Clin Radiol

  8. MA K, Zhu Y, Liu W, Zhu X, et al
    CMR-based estimation of mean pulmonary arterial pressure and pulmonary vascular resistance in connective tissue disease-associated pulmonary arterial hypertension.
    Clin Radiol. 2026;93:107199.
    PubMed         Abstract available


    Clin Rheumatol

  9. QIAN W, Zhang Y, Dai J, Shan L, et al
    TAPSE/PASP combined with IVC can identify poor prognosis in PAH patients with low and intermediate risk.
    Clin Rheumatol. 2026;45:1215-1224.
    PubMed         Abstract available


    FASEB J

  10. FENG W, Bai D, Mo S, Wen D, et al
    Echinatin Alleviates Experimental Pulmonary Hypertension by PPARgamma Pathway Activation.
    FASEB J. 2026;40:e71542.
    PubMed         Abstract available


    Front Cardiovasc Med

  11. MOREIRA-COSTA L, Leite-Moreira A, Adao R, Laville D, et al
    A swine model of severe chronic thromboembolic pulmonary hypertension induced by repeated pulmonary artery long suture injection.
    Front Cardiovasc Med. 2026;12:1736958.
    PubMed         Abstract available

  12. YUAN S, Hu X, Zhao Y, Dai H, et al
    Case Report: Immune checkpoint inhibitor-associated pulmonary hypertension.
    Front Cardiovasc Med. 2026;12:1705102.
    PubMed         Abstract available


    Hypertension

  13. LI SS, Guo M, Zhao Y, Huang S, et al
    circMFN2 Regulates the IGF2BP3-PDK4 to Ameliorate Pulmonary Hypertension.
    Hypertension. 2026 Feb 5. doi: 10.1161/HYPERTENSIONAHA.125.25460.
    PubMed         Abstract available


    Int Immunopharmacol

  14. LI Z, Chen K, Wu W
    Right atrial CCR2(+) macrophages mediate atrial fibrillation in rat with monocrotaline-induced pulmonary arterial hypertension.
    Int Immunopharmacol. 2026;172:115920.
    PubMed         Abstract available


    Int J Rheum Dis

  15. SUBEDI BK, Gautam N, Ali R, Tan IJ, et al
    Impact of Hydroxychloroquine on Mortality and Cardiovascular Outcomes in Systemic Sclerosis: A Retrospective Cohort Study.
    Int J Rheum Dis. 2026;29:e70515.
    PubMed         Abstract available


    J Cardiothorac Surg

  16. ISHIDA N, Oishi H, Niikawa H, Suzuki T, et al
    Bilateral lung transplantation with simultaneous aortic replacement using donor aorta in a patient with pulmonary arterial hypertension and patent ductus arteriosus.
    J Cardiothorac Surg. 2026;21:64.
    PubMed         Abstract available


    J Ethnopharmacol

  17. CHEN Q, Jia N, Zhang X, Liu J, et al
    Calycosin ameliorates high-altitude pulmonary edema by regulating macrophage polarization through the PPAR-gamma/NF-kappaB pathway: a comprehensive analysis of network pharmacology, molecular docking, and experimental validation.
    J Ethnopharmacol. 2026;360:121200.
    PubMed         Abstract available


    J Mol Cell Cardiol

  18. CACHEUX M, Strauss B, Parajuli S, Halouani A, et al
    Extracellular-cAMP suppresses pulmonary arterial hypertension-induced ventricular arrhythmias.
    J Mol Cell Cardiol. 2026;211:109-118.
    PubMed         Abstract available


    J Perinatol

  19. GOPAGONDANAHALLI KR, Tan JM, Khoo May Lyn J, Sundararaghavan S, et al
    Variable clinical and hemodynamic effect of sildenafil in extreme premature infants with bronchopulmonary dysplasia-associated pulmonary hypertension.
    J Perinatol. 2026 Feb 5. doi: 10.1038/s41372-026-02578.
    PubMed         Abstract available


    J Thorac Cardiovasc Surg

  20. SHENTU J, Dai W, Chen C, Huang J, et al
    A Novel Rat Model for Group 2 Pulmonary Hypertension by Total Pulmonary Vein Banding: Multi-Omics Insights into Pathophysiological Mechanisms.
    J Thorac Cardiovasc Surg. 2026 Jan 29:S0022-5223(26)00085.
    PubMed         Abstract available


    JMIR Cardio

  21. TAKITA Y, Morishita J, Park S, Goda A, et al
    Mindfulness-Based Self-Management Program Using a Mobile App for Patients With Pulmonary Hypertension: Single-Arm Feasibility Study.
    JMIR Cardio. 2026;10:e79639.
    PubMed         Abstract available


    Med Lett Drugs Ther


  22. A treprostinil inhaler (Yutrepia) for pulmonary hypertension.
    Med Lett Drugs Ther. 2026;68:27-28.
    PubMed        


    Medicine (Baltimore)

  23. WU C, Zhao W, Zhu X, Li Y, et al
    Identification and genetic validation of potential therapeutic targets for pulmonary hypertension through multi-omics causal inference.
    Medicine (Baltimore). 2026;105:e47525.
    PubMed         Abstract available


    Mol Cell Biochem

  24. CHEN A, Chen Z, Huang B, Lian G, et al
    Correction to: Hypoxia-induced histone lactylation promotes pulmonary arterial smooth muscle cells proliferation in pulmonary hypertension.
    Mol Cell Biochem. 2026 Feb 5. doi: 10.1007/s11010-026-05493.
    PubMed        


    Pediatr Neonatol

  25. KANAGARAJ UK, Kuan MTY, Castaldo M, Skarsgard E, et al
    Liver herniation in congenital diaphragmatic hernia is associated with delayed resolution of pulmonary hypertension.
    Pediatr Neonatol. 2026 Jan 22:S1875-9572(26)00004.
    PubMed         Abstract available


    PLoS One

  26. CHEN KL, Duemmel S, Christof M, Wang G, et al
    Mixed effects of complement in a chronic murine model of inflammatory erosive arthritis and pulmonary vascular disease.
    PLoS One. 2026;21:e0340677.
    PubMed         Abstract available


    Pol Arch Intern Med

  27. FILIPIAK J, Dzikowska-Diduch O, Justyna A, Labyk A, et al
    How long does chronic thromboembolic pulmonary hypertension take to develop? Two cases of post?thrombotic complete occlusion of the left pulmonary artery.
    Pol Arch Intern Med. 2026 Feb 3:17220. doi: 10.20452/pamw.17220.
    PubMed        


    Pulm Circ

  28. BOCHENEK ML, Ghasemi I, Wiedenroth CB, Bikou O, et al
    Transmembrane Protein 100 Expression on Endothelial Cells Vascularizing Thrombi in Chronic Thromboembolic Pulmonary Hypertension Modulates TGFbeta1-ALK1 Signaling During Angiogenesis.
    Pulm Circ. 2026;16:e70253.
    PubMed         Abstract available


    Pulm Med

  29. DHAYYAT A, Stavem K, Jervan O, Hilde JM, et al
    Stress Echocardiography to Detect Exercise Pulmonary Hypertension in Patients With Chronic Thromboembolic Pulmonary Disease.
    Pulm Med. 2026;2026:4127338.
    PubMed         Abstract available


    Respir Med

  30. DE MARCO T, Paoli CJ, Germack HD, Croteau NS, et al
    Exploring the relationship between adherence and outcomes in pulmonary arterial hypertension: A retrospective cohort study in the United States.
    Respir Med. 2026;252:108649.
    PubMed         Abstract available


    Respirology

  31. PLUNKETT MJ, Sayegh ALC, Lewis RA, McWilliams TJ, et al
    Sympatho-Excitation in Pulmonary Hypertension: The Potential Role of Pulmonary Arterial Baroreceptors: An Acute Physiologic Intervention Study.
    Respirology. 2026 Feb 3. doi: 10.1002/resp.70207.
    PubMed         Abstract available

  32. SUZUKI Y, Nagaoka T, Nagata Y, Terayama Y, et al
    Transplantation of Ex Vivo Amplified Mononuclear Cells From Peripheral Blood Improves Rat Pulmonary Hypertension via CD14- and CD163-Positive M2 Macrophages.
    Respirology. 2026 Feb 4. doi: 10.1002/resp.70206.
    PubMed         Abstract available


    Rheumatology (Oxford)

  33. LUI JK, Cozzolino M, Winburn M, Trojanowski MA, et al
    Risk stratifying systemic sclerosis-related pulmonary hypertension by left atrial strain.
    Rheumatology (Oxford). 2026 Jan 30:keag053. doi: 10.1093.
    PubMed         Abstract available

  34. WATTANARAT B, Foocharoen C, Panitchote A
    Clinical predictors of mortality in critically ill systemic sclerosis patients: a 6-year retrospective cohort study.
    Rheumatology (Oxford). 2026;65:keag008.
    PubMed         Abstract available


    Saudi Med J

  35. HOMEDI A, Ali Ali K, Almehaid A, Alrahili M, et al
    Targeted Neonatal Echocardiography and Neonatal Hemodynamics in the Kingdom of Saudi Arabia: A One-Year Experience in Service Implementation.
    Saudi Med J. 2026;47:60-66.
    PubMed         Abstract available


    Sci Rep

  36. SHAUKAT M, Grunig E, Haas S, Haas J, et al
    Heritable pulmonary arterial hypertension: new genetic findings and environmental triggers.
    Sci Rep. 2026;16:4121.
    PubMed         Abstract available

  37. CHI L, Foley AE, Goodarzi G, Volchuk A, et al
    The hypoxic tight-skin mouse model of Group 3 pulmonary hypertension.
    Sci Rep. 2026 Feb 2. doi: 10.1038/s41598-026-38174.
    PubMed         Abstract available


    Sci Transl Med

  38. LIU T, Zhou W, Fang C, Liang Y, et al
    Sine oculis homeobox 1 drives endothelial dysfunction in preclinical pulmonary arterial hypertension.
    Sci Transl Med. 2026;18:eadu6425.
    PubMed         Abstract available


    Stem Cell Res Ther

  39. WANG J, Jin J, Zhang M, Chen X, et al
    Mesenchymal stromal cells alleviate pulmonary arterial hypertension by suppressing pulmonary arterial adventitial fibroblast activation and extracellular matrix remodeling via the SOCS3/STAT3 pathway.
    Stem Cell Res Ther. 2026;17:67.
    PubMed         Abstract available


    Zhonghua Jie He He Hu Xi Za Zhi

  40. JIANG YH, Zhang ZL, Qin N, Luo XY, et al
    [Role of macrophages in pulmonary arterial hypertension and advances in targeted therapeutic interventions].
    Zhonghua Jie He He Hu Xi Za Zhi. 2026;49:215-222.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum